Skip to main content
Log in

Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of our study is to carry out a Bayesian network meta-analysis comparing the efficacy of different antimicrobial lock solutions (ALS) for prevention of catheter-related infections (CRI) in patients with hemodialysis (HD) and ranking these ALS for practical consideration.

Methods

We searched six electronic databases, earlier relevant meta-analysis and reference lists of included studies for randomized controlled trials (RCTs) that compared ALS for preventing episodes of CRI in patients with HD either head-to-head or against control interventions using non-ALS. Two authors independently assessed the methodological quality of included studies using the Cochrane risk of bias tool and extracted relevant information according to a predesigned extraction form. Data were analysed using the WinBUGS (V.1.4.3) and the Stata (V.13.0).

Results

Finally, 18 studies involving 2395 patients and evaluating 9 ALS strategies were included. Network meta-analysis showed that gentamicin plus citrate (OR 0.07, 95% CrI 0.00–0.48) and gentamicin plus heparin (OR 0.04, 95% CrI 0.00–0.23) were statistically superior to heparin alone in terms of reducing CRBSI. For exit site infection and all-cause mortality, no significant difference in the intervention effect (p > 0.05) was detected for all included ALS when compared to heparin. Moreover, all ALS were similar in efficacy (p > 0.05) from each other for CRBSI, exit site infection and all-cause mortality.

Conclusions

Our findings indicated that gentamicin plus heparin may be selected for the prophylaxis of CRI in patients undergoing HD with CVCs. Whether this strategy will lead to antimicrobial resistance remains unclear in view of the relatively short duration of included studies. More attentions should be made regarding head-to-head comparisons of the most commonly used ALS in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Rehman R, Schmidt RJ, Moss AH (2009) Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 4:456–460

    Article  PubMed  Google Scholar 

  2. Rayner HC, Besarab A, Brown WW et al (2004) Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 44:22–26

    Article  PubMed  Google Scholar 

  3. Pisoni RL, Young EW, Dykstra DM et al (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61:305–316

    Article  PubMed  Google Scholar 

  4. Lacson E Jr, Lazarus JM, Himmelfarb J et al (2007) Balancing fistula first with catheters last. Am J Kidney Dis 50:379–395

    Article  PubMed  Google Scholar 

  5. Taylor G, Gravel D, Johnston L et al (2002) Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23:716–720

    Article  PubMed  Google Scholar 

  6. Silva TN, de Marchi D, Mendes ML et al (2014) Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: a critical review. Hemodial Int 18:15–23

    Article  PubMed  Google Scholar 

  7. Katneni R, Hedayati SS (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3:256–266

    Article  PubMed  Google Scholar 

  8. Ishani A, Collins AJ, Herzog CA et al (2005) Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68:311–318

    Article  PubMed  Google Scholar 

  9. Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539

    Article  PubMed  Google Scholar 

  10. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322

    Article  CAS  PubMed  Google Scholar 

  11. Donlan RM (2001) Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 33:1387–1392

    Article  CAS  PubMed  Google Scholar 

  12. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45:999–1007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133–2139

    Article  CAS  PubMed  Google Scholar 

  14. Betjes MG, van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19:1546–1551

    Article  CAS  PubMed  Google Scholar 

  15. Bleyer AJ, Mason L, Russell G et al (2005) A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520–524

    Article  PubMed  Google Scholar 

  16. Snaterse M, Rüger W, Scholte Op Reimer WJ et al (2010) Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 75:1–11

    Article  CAS  PubMed  Google Scholar 

  17. Rabindranath KS, Bansal T, Adams J et al (2009) Systematic review of antimicrobials for the prevention of hemodialysis catheter-related infections. Nephrol Dial Transplant 24:3763–3774

    Article  CAS  PubMed  Google Scholar 

  18. Yahav D, Rozen-Zvi B, Gafter-Gvili A et al (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83–93

    Article  PubMed  Google Scholar 

  19. Liu H, Liu H, Deng J et al (2014) Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood Purif 37:179–187

    Article  CAS  PubMed  Google Scholar 

  20. Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63:479–490

    Article  CAS  PubMed  Google Scholar 

  21. Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105–3124

    Article  CAS  PubMed  Google Scholar 

  22. Jansen JP, Crawford B, Bergman G et al (2008) Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 11:956–964

    Article  PubMed  Google Scholar 

  23. Catalá-López F, Tobías A, Cameron C et al (2014) Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int 34:1489–1496

    Article  PubMed  Google Scholar 

  24. O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1–29

    PubMed  Google Scholar 

  25. Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928

    Article  PubMed  PubMed Central  Google Scholar 

  26. Shriner D, Yi N (2009) Deviance information criterion (DIC) in Bayesian multiple QTL mapping. Comput Stat Data Anal 53:1850–1860

    Article  PubMed  PubMed Central  Google Scholar 

  27. Brooks SP, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434–445

    Google Scholar 

  28. McIntyre CW, Hulme LJ, Taal M et al (2004) Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801–805

    Article  PubMed  Google Scholar 

  29. Saxena AK, Panhotra BR (2005) The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol 18:755–763

    CAS  PubMed  Google Scholar 

  30. Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769–2777

    Article  CAS  PubMed  Google Scholar 

  31. Nori US, Manoharan A, Yee J et al (2006) Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48:596–605

    Article  CAS  PubMed  Google Scholar 

  32. Macrae JM, Dojcinovic I, Djurdjev O et al (2009) Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3:369–374

    Article  Google Scholar 

  33. Tan HZ (2008) A randomized controlled study on prevention of catheter-related bacteremia with gentamicin-heparin lock solution. Dissertation, Zhejiang University

  34. Zhang P, Yuan J, Tan H et al (2009) Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif 27:206–211

    Article  PubMed  Google Scholar 

  35. Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55:1060–1068

    Article  CAS  PubMed  Google Scholar 

  36. Campos RP, do Nascimento MM, Chula DC et al (2011) Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 22:1939–1945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Filiopoulos V, Hadjiyannakos D, Koutis I et al (2011) Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol 33:260–268

    Article  PubMed  Google Scholar 

  38. Lu DS (2011) Gentamicin lock solution prevents central venous catheter-related infections in hemodialysis. Med Inform 24:123–124

    Google Scholar 

  39. Broom JK, Krishnasamy R, Hawley CM et al (2012) A randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in hemodialysis patients–the HEALTHY-CATH trial. BMC Nephrol 13:146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Moran J, Sun S, Khababa I et al (2012) A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 59:102–107

    Article  CAS  PubMed  Google Scholar 

  41. Sofroniadou S, Revela I, Smirloglou D et al (2012) Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study. Semin Dial 25:344–350

    Article  PubMed  Google Scholar 

  42. Hu ZX, Xiao HQ, Fei P (2013) Application of the lock solution containing l% cefazolin/30% sodium citrate for long-term indwelling catheters in maintenance hemodialysis patient. Chin J Blood Purif 12:602–604

    Google Scholar 

  43. Zacharioudakis IM, Zervou FN, Arvanitis M et al (2014) Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis 59:1741–1749

    Article  PubMed  Google Scholar 

  44. Oliver MJ, Callery SM, Thorpe KE et al (2000) Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 58:2543–2545

    Article  CAS  PubMed  Google Scholar 

  45. Wang AY, Ivany JN, Perkovic V et al (2013) Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant 28:2875–2888

    Article  CAS  PubMed  Google Scholar 

  46. Landry DL, Braden GL, Gobeille SL et al (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5:1799–1804

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jun Zhang or Jinhui Tian.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Wang, B., Li, R. et al. Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis. Int Urol Nephrol 49, 701–716 (2017). https://doi.org/10.1007/s11255-016-1490-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-016-1490-x

Keywords

Navigation